


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+3.92%
+2.21%
+1.04%
-2.33%
+1.30%
CRSP
CRISPR Therapeutics
$53.35
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

Outperform the market

Investors confidence is positive
CRSP Price Performance
$52.44 (+1.74%)
$61.97 (-13.91%)
$54.86 (-2.75%)
$43.49 (+22.67%)
Overall standing based on market and analyst consensus.
Hover over the category for more information
Earnings
Earnings

Below analyst estimate
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity

Investors confidence is positive
Future
Future

Earnings are forecast to grow

Outperform the market

Trading below its fair value
![]()
CRSP Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
CRSP Street Sentiment is extremely bullish and have positive views on the near-term outlook
CRSP has Fair risk level
Risks Indicators

Beta greater than 1.0

Average key support and resistance price levels
IBRX
5.91
-3.90%
CLDI
1.05
+1.94%
BNTX
116.77
+0.53%
BEAM
29.29
+0.93%
AMGN
342.94
+0.21%
CRSP
CRISPR Therapeutics
53.35
-0.63%
BKNG
Booking Holdings Inc
5113.32
+0.55%
RSKD
Riskified Ltd.
4.34
-2.91%
AZN
Astrazeneca
92.59
-0.68%
NIO
NIO
4.77
+3.92%
What is CRSP current stock price?
What are CRSP stock strengths?
What is CRSP Risk Level?
What is CRSP market cap and volume?
What is CRSP current Stock IQ?
Should I buy CRSP stock right now?
Is CRSP a Strong Buy right now?
What does a 'Strong Buy' rating mean for CRSP?
What does a 'Strong Sell' rating mean for CRSP?
What factors influence CRSP's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+3.92%
+2.21%
+1.04%
-2.33%
+1.30%
CRSP
CRISPR Therapeutics
Current Price
$53.35
Stock Insights
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

Outperform the market

Investors confidence is positive
Linked to CRSP
IBRX
5.91
-3.90%
CLDI
1.05
+1.94%
BNTX
116.77
+0.53%
BEAM
29.29
+0.93%
AMGN
342.94
+0.21%
Recently Viewed
CRSP
CRISPR Therapeutics
53.35
-0.63%
BKNG
Booking Holdings Inc
5113.32
+0.55%
RSKD
Riskified Ltd.
4.34
-2.91%
AZN
Astrazeneca
92.59
-0.68%
NIO
NIO
4.77
+3.92%

CRSP Price Performance
$52.44 (+1.74%)
$61.97 (-13.91%)
$54.86 (-2.75%)
$43.49 (+22.67%)
CRSP Analysts Opinion
Overall standing per market and analyst expectations.
Hover over the category for more information
Earnings
Earnings

Below analyst estimate
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity

Investors confidence is positive
Future
Future

Earnings are forecast to grow

Outperform the market

Trading below its fair value
![]()
CRSP Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
CRSP Street Sentiment is extremely bullish and have positive views on the near-term outlook
CRSP has Fair risk level
Risks Indicators

Beta greater than 1.0

Average key support and resistance price levels
Overall Wall Street Rating
STRONG BUY
Dec 31, 2025
Reiterate
Buy
Chardan
Dec 24, 2025
Reiterate
Buy
Needham
Dec 24, 2025
Reiterate
Outperform
Citizens
Nov 13, 2025
Reiterate
Buy
Citigroup
Oct 17, 2025
Reiterate
Buy
B of A Securities
CRSP Stock IQ
CRSP Latest Analysis
What Does the Market Think About CRISPR Therapeutics AG?. CRSP) short interest as a percent of float has fallen 3.73% since its last report. According to exchange reported data there are now Short interest is the number of shares that have been sold short but have not yet been covered or closed out. is when a trader sells shares of a company they do not own with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.Sho
Thu Jan 29, 2026
CRISPR Therapeutics AG (CRSP) Is a Trending Stock: Facts to Know Before Betting on It. CRISPR Therapeutics (CRSP) has received quite a bit of attention from Zacks.com users lately. Therefore it is wise to be aware of the facts that can impact the stocks prospects.
Mon Jan 26, 2026
CRISPR Therapeutics AG (CRSP) Stock Declines While Market Improves: Some Information for Investors. CRISPR Therapeutics AG (CRSP) concluded the recent trading session at $54.21 signifying a -4.71% move from its prior days close.
Thu Jan 15, 2026
Crispr Therapeutics: Patience And Opportunity Through Volatility.
Wed Jan 14, 2026
CRISPR Therapeutics AG (CRSP) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript.
Mon Jan 12, 2026
CRISPR Therapeutics (CRSP) Is Considered a Good Investment by Brokers: Is That True?. Based on the average brokerage recommendation (ABR) CRISPR Therapeutics (CRSP) should be added to ones portfolio. Wall Street analysts overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So is the stock worth buying?
Mon Jan 12, 2026
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
CRSP Stock trends
CRSP Stock performance
CRSP Stock analysis
CRSP investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.